Literature DB >> 6696818

Cellular DNA content--a stable feature in epithelial ovarian cancer.

M L Friedlander, I W Taylor, P Russell, M H Tattersall.   

Abstract

Detailed flow cytometric analysis of cellular DNA content was performed on neoplastic tissue from 33 patients with malignant common epithelial ovarian tumours in order to investigate the intratumoral stability of ploidy and proliferative fraction. There was a remarkable stability, both spatial and temporal, in the DNA pattern for any particular tumour. Of 24 tumours that were analysed in multiple areas tumour ploidy was found to be a stable marker in all but 3 cases where regional variations were evident. In 9 patients serial analyses were performed on tumour obtained either at initial diagnosis (6 patients) or second look laparotomy (3 patients) and then some time later (7-17 months) at relapse or death and in all cases the tumour ploidy remained unchanged. In addition, 10 ovarian carcinomas established in nude mice have maintained a DNA content during serial passage similar to that of the original implanted tumour. In contrast in 50% of tumours that were evaluable for S-phase analysis we demonstrated a considerable intratumoral variability in the S-phase fraction. We conclude that cellular DNA content is a stable feature of ovarian carcinoma while S-phase fraction is commonly subject to intratumoral variation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6696818      PMCID: PMC1976707          DOI: 10.1038/bjc.1984.29

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  19 in total

1.  Modal DNA value and chromosome number in ovarian neoplasia. A clinical and histopathologic assessment.

Authors:  N B Atkin
Journal:  Cancer       Date:  1971-05       Impact factor: 6.860

2.  A rapid single step staining technique for DNA analysis by flow microfluorimetry.

Authors:  I W Taylor
Journal:  J Histochem Cytochem       Date:  1980-09       Impact factor: 2.479

3.  An evaluation of DNA fluorochromes, staining techniques, and analysis for flow cytometry. I. Unperturbed cell populations.

Authors:  I W Taylor; B K Milthorpe
Journal:  J Histochem Cytochem       Date:  1980-11       Impact factor: 2.479

4.  Determination of ploidy and proliferative characteristics of human solid tumors by pulse cytophotometry.

Authors:  B Barlogie; W Göhde; D A Johnston; L Smallwood; J Schumann; B Drewinko; E J Freireich
Journal:  Cancer Res       Date:  1978-10       Impact factor: 12.701

5.  Cellular DNA content as a marker of neoplasia in man.

Authors:  B Barlogie; B Drewinko; J Schumann; W Göhde; G Dosik; J Latreille; D A Johnston; E J Freireich
Journal:  Am J Med       Date:  1980-08       Impact factor: 4.965

6.  FMFPAK1: a program package for routine analysis of single parameter flow microfluorimetric data on a low cost mini-computer.

Authors:  B Milthorpe
Journal:  Comput Biomed Res       Date:  1980-10

7.  Correlation of DNA distribution abnormalities with cytogenetic findings in human adult leukemia and lymphoma.

Authors:  B Barlogie; W Hittelman; G Spitzer; J M Trujilo; J S Hart; L Smallwood; B Drewinko
Journal:  Cancer Res       Date:  1977-12       Impact factor: 12.701

8.  Clonal heterogeneity of small-cell anaplastic carcinoma of the lung demonstrated by flow-cytometric DNA analysis.

Authors:  L L Vindeløv; H H Hansen; I J Christensen; M Spang-Thomsen; F R Hirsch; M Hansen; N I Nissen
Journal:  Cancer Res       Date:  1980-11       Impact factor: 12.701

9.  Flow cytometry of DNA content in human bone marrow: a critical reappraisal.

Authors:  G M Dosik; B Barlogie; W Göhde; D Johnston; J L Tekell; B Drewinko
Journal:  Blood       Date:  1980-05       Impact factor: 22.113

10.  Ploidy as a prognostic factor in ovarian cancer.

Authors:  M L Friedlander; I W Taylor; P Russell; E A Musgrove; D H Hedley; M H Tattersall
Journal:  Int J Gynecol Pathol       Date:  1983       Impact factor: 2.762

View more
  7 in total

Review 1.  Clinical and biological significance of aneuploidy in human tumours.

Authors:  M L Friedlander; D W Hedley; I W Taylor
Journal:  J Clin Pathol       Date:  1984-09       Impact factor: 3.411

2.  Multivariate analyses of DNA index, p62c-myc, and clinicopathological status of patients with ovarian cancer.

Authors:  M Curling; S Stenning; C N Hudson; J V Watson
Journal:  J Clin Pathol       Date:  1998-06       Impact factor: 3.411

3.  DNA ploidy of primary hepatocellular carcinoma and pulmonary metastases.

Authors:  Y Yoshida; T Kanematsu; D Korenaga; T Sonoda; K Sugimachi
Journal:  Clin Exp Metastasis       Date:  1992-09       Impact factor: 5.150

4.  Flow cytometric analysis of DNA content in human ovarian cancers.

Authors:  E Erba; P Ubezio; S Pepe; M Vaghi; S Marsoni; W Torri; C Mangioni; F Landoni; M D'Incalci
Journal:  Br J Cancer       Date:  1989-07       Impact factor: 7.640

5.  Tumour ploidy, response and survival in patients receiving endocrine therapy for advanced breast cancer.

Authors:  R Stuart-Harris; D W Hedley; I W Taylor; A L Levene; I E Smith
Journal:  Br J Cancer       Date:  1985-04       Impact factor: 7.640

6.  Tumour cell activity markers in epithelial ovarian cancer: are biochemical and cytometric indices complementary?

Authors:  C W Redman; C Finn; K Ward; K Kelly; E J Buxton; R Varma; W Shortland-Webb; D M Luesley
Journal:  Br J Cancer       Date:  1990-05       Impact factor: 7.640

7.  DNA index of ovarian carcinomas from 56 patients: in vivo in vitro studies.

Authors:  E Erba; M Vaghi; S Pepe; G Amato; M Bistolfi; P Ubezio; C Mangioni; F Landoni; L Morasca
Journal:  Br J Cancer       Date:  1985-10       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.